Gastroenterology and Hepatology - Issue 6/2016
475
Some genetic determinants of celiac disease, the role of HLA haplotyping in clinical settings and HLA-DQ haplotypes in a group of 306 pediatric patients
M. Kubina, I. Čierna, D. Székyová, L. Kovács
480
Importance of faecal calprotectin in screening and clinical assessment of adult and pediatric patients with inflammatory bowel diseases
I. Čopová, O. Hradský, K. Zárubová, L. Gonsorčíková, J. Bronský
Bariatrics
485
Recent bariatric-metabolic surgery
P. Holéczy, M. Bužga
491
The duodenal-jejunal bypass liner (EndoBarrier®) for the treatment of type 2 diabetes mellitus in obese patients – efficacy and factors predicting optimal effects
M. Beneš, T. Hucl, P. Drastich, R. Keil, Z. Vlasáková, T. Pelikánová, P. Kaválková, M. Mráz, Z. Lacinová, M. Haluzík, J. Špičák
Hepatology
500
IDB: Original Article
509
Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical practice
Luděk Hrdlička, M. Bortlík, T. Douda, P. Drastich, Přemysl Falt, P. Matějková, J. Koželuhová, M. Liberda, L. Nedbalová, A. Novotný, M. Kolář, M. Lukáš
514
Biosimilar infliximab in anti-TNF-naïve IBD patients – 1-year clinical follow-up
M. Kolár, D. Ďuricová, M. Bortlík, V. Hrubá, N. Machková, K. Mitrová, K. Malickova, M. Lukas Jr, M. Lukas
Gastroenterology and Hepatology
2016 Issue 6
Most read in this issue
- Importance of faecal calprotectin in screening and clinical assessment of adult and pediatric patients with inflammatory bowel diseases
- Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical practice
- The duodenal-jejunal bypass liner (EndoBarrier®) for the treatment of type 2 diabetes mellitus in obese patients – efficacy and factors predicting optimal effects
- Some genetic determinants of celiac disease, the role of HLA haplotyping in clinical settings and HLA-DQ haplotypes in a group of 306 pediatric patients